Literature DB >> 11709004

Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation.

C González-Rubio1, A Ferreira-Cerdán, I M Ponce, J Arpa, G Fontán, M López-Trascasa.   

Abstract

BACKGROUND: Complement (C) factor I deficiency is a rare immunodeficiency state frequently associated with recurrent pyogenic infections in early infancy. This deficiency causes a permanent uncontrolled activation of the alternative pathway resulting in massive consumption of C3. PATIENT: A 23-year-old woman with monthly recurrent meningitis episodes, mostly in the perimenstrual period, since August 1999. Previously, at age 16 years, she had meningococcal sepsis, also coinciding with menstruation.
OBJECTIVES: To study the patient and her family to elucidate the molecular defects in the pedigree and to evaluate her clinical evolution.
RESULTS: We describe clinical, immunological, and treatment follow-up during this period. First, we characterized the existence of a total complement factor I deficiency defined by undetectable levels by enzyme immunosorbent assay. This total deficiency was also found in her sister. Her parents and brother had approximately half of the normal levels. In addition, the patient had very low levels of C3; factor B; and an important reduction of factor H, properdin, C5, C7, and C8 complement components. Additional studies in the patient's sera evidenced high levels of immune complexes containing C1q and immunoglobulin (Ig) G, as well as C3b/factor H, C3b/properdin, C3b/IgG, and properdin/IgG complexes. Treatment with prophylactic antibiotics, antiestrogen medication, plasma infusions, or intravenous immunoglobulin has been unsuccessful in avoiding consecutive meningitis episodes.
CONCLUSION: For the first time to our knowledge, these data present an unusual relationship between meningitis episodes and menstruation in factor I immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709004     DOI: 10.1001/archneur.58.11.1923

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

Review 1.  Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis.

Authors:  Marc Tebruegge; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

2.  Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.

Authors:  Elena Goicoechea de Jorge; Claire L Harris; Jorge Esparza-Gordillo; Luis Carreras; Elena Aller Arranz; Cynthia Abarrategui Garrido; Margarita López-Trascasa; Pilar Sánchez-Corral; B Paul Morgan; Santiago Rodríguez de Córdoba
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-20       Impact factor: 11.205

3.  The clinical and laboratory features of Chinese Han anti-factor H autoantibody-associated hemolytic uremic syndrome.

Authors:  Di Song; Xiao-Rong Liu; Zhi Chen; Hui-Jie Xiao; Jie Ding; Shu-Zhen Sun; Hong-Yan Liu; Wei-Yi Guo; Su-Xia Wang; Feng Yu; Ming-Hui Zhao
Journal:  Pediatr Nephrol       Date:  2016-12-29       Impact factor: 3.714

4.  Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.

Authors:  Rubén Martínez-Barricarte; Meike Heurich; Francisco Valdes-Cañedo; Eduardo Vazquez-Martul; Eva Torreira; Tamara Montes; Agustín Tortajada; Sheila Pinto; Margarita Lopez-Trascasa; B Paul Morgan; Oscar Llorca; Claire L Harris; Santiago Rodríguez de Córdoba
Journal:  J Clin Invest       Date:  2010-09-13       Impact factor: 14.808

5.  A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome.

Authors:  Joyce Geelen; Koen van den Dries; Anja Roos; Nicole van de Kar; Corrie de Kat Angelino; Ina Klasen; Leo Monnens; Lambertus van den Heuvel
Journal:  Pediatr Nephrol       Date:  2006-11-15       Impact factor: 3.714

Review 6.  Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis.

Authors:  Lori Broderick; Chhavi Gandhi; James L Mueller; Christopher D Putnam; Katayoon Shayan; Patricia C Giclas; Karin S Peterson; Seema S Aceves; Robert M Sheets; Bradley M Peterson; Robert O Newbury; Hal M Hoffman; John F Bastian
Journal:  J Clin Immunol       Date:  2012-08-29       Impact factor: 8.317

7.  Complete factor I deficiency due to dysfunctional factor I with recurrent aseptic meningo-encephalitis.

Authors:  Filomeen Haerynck; Patrick Stordeur; Johan Vandewalle; Rudy Van Coster; Victoria Bordon; Frans De Baets; Petra Schelstraete; Cédric Javaux; Marie-Rose Bouvry; Véronique Fremeaux-Bacchi; Joke Dehoorne
Journal:  J Clin Immunol       Date:  2013-10-20       Impact factor: 8.317

8.  Complement factor I deficiency: a not so rare immune defect: characterization of new mutations and the first large gene deletion.

Authors:  María Alba-Domínguez; Alberto López-Lera; Sofía Garrido; Pilar Nozal; Ignacio González-Granado; Josefa Melero; Pere Soler-Palacín; Carmen Cámara; Margarita López-Trascasa
Journal:  Orphanet J Rare Dis       Date:  2012-06-18       Impact factor: 4.123

9.  Complement mutations in diacylglycerol kinase-ε-associated atypical hemolytic uremic syndrome.

Authors:  Daniel Sánchez Chinchilla; Sheila Pinto; Bernd Hoppe; Marta Adragna; Laura Lopez; Maria Luisa Justa Roldan; Antonia Peña; Margarita Lopez Trascasa; Pilar Sánchez-Corral; Santiago Rodríguez de Córdoba
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-18       Impact factor: 10.614

10.  Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.

Authors:  Kirsten L Rose; Danielle Paixao-Cavalcante; Jennifer Fish; Anthony P Manderson; Talat H Malik; Anne E Bygrave; Tao Lin; Steven H Sacks; Mark J Walport; H Terence Cook; Marina Botto; Matthew C Pickering
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.